发明公开
- 专利标题: STEREOSPECIFIC SYNTHESIS PROCESS FOR TRETINOIN COMPOUNDS
- 专利标题(中): 丁二酮化合物的立体异构合成方法
-
申请号: EP12786430.4申请日: 2012-05-07
-
公开(公告)号: EP2708530A1公开(公告)日: 2014-03-19
- 发明人: DENG, Qingjun , WANG, Shaohui , ZHU, Qiang , GAO, Taiping , LI, Yongsheng
- 申请人: Chongqing Huabangshengkai Pharm. Co., Ltd
- 申请人地址: No. 666 Rongjun Road Nanjin Street Sub-district Hechuan District Chongqing 401520 CN
- 专利权人: Chongqing Huabangshengkai Pharm. Co., Ltd
- 当前专利权人: Chongqing Huabangshengkai Pharm. Co., Ltd
- 当前专利权人地址: No. 666 Rongjun Road Nanjin Street Sub-district Hechuan District Chongqing 401520 CN
- 代理机构: Grünecker, Kinkeldey, Stockmair & Schwanhäusser
- 优先权: CN201110124227 20110513
- 国际公布: WO2012155796 20121122
- 主分类号: C07C403/20
- IPC分类号: C07C403/20
摘要:
A stereospecific synthesis process for tretinoin compounds comprises the following steps: using substituted triphenyl phosphine salt and β-formyl crotonic acid as raw material to carry out WITTIG reaction under the action of alkali; then adjusting the pH of the reaction liquid to 5-10; adding palladium compound or rhodium compound to carry out isomerization directly and obtain tretinoin compounds with desired configuration. The product yield of the process is high and the intermediate product in the reaction dose not need to be separated. The process is easy to operate and can save the production cost and as well is suitable for industrial production.
公开/授权文献
- EP2708530B1 STEREOSPECIFIC SYNTHESIS PROCESS FOR TRETINOIN COMPOUNDS 公开/授权日:2016-08-10
信息查询